SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about outcome of board meeting

03 Jun 2021 Evaluate

Lupin has informed that the Board of Directors has approved the Company’s entry into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India. The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2485.80 9.70 (0.39%)
06-Jul-2026 10:44 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1908.65
Dr. Reddys Labs. 1366.35
Cipla 1456.00
Zydus Lifesciences 1145.00
Lupin 2485.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: